Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-15858A |
Brand: | MCE |
CAS: | 2070014-95-6 |
MDL | - |
---|---|
Molecular Weight | 631.18 |
Molecular Formula | C31H44ClFN8O3 |
SMILES | FC1=CC=C(CNC2=NC(NCC3CCCCC3)=NC(NC4=CC=C(CC(NCCOCCOCCN)=O)C=C4)=N2)C=C1.Cl |
IC 50 : 0.576 uM (enolase) [1]
AP-III-a4 (ENOblock) (0-10 μM; 24 h) inhibits HCT116 cell viability in a dose-dependent manner
[1]
.
AP-III-a4 directly binds to enolase and inhibits its activity
[1]
.
AP-III-a4 (0-10 μM; 24 or 48 h) inhibits cancer cell migration and invasion, induces cancer cell apoptosis
[1]
.
AP-III-a4 (10 μM; 24 h) can induce glucose uptake and inhibit phosphoenolpyruvate carboxykinase (PEPCK) expression in hepatocytes and kidney cells
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
Cell Line: | HCT116 |
Concentration: | 1.25, 2.5, 5 and 10 μM |
Incubation Time: | 24 h |
Result: | Induced higher levels of HCT116 colon cancer cell death in hypoxic conditions compared to normoxia. |
Western Blot Analysis [1]
Cell Line: | HCT116 |
Concentration: | 1.25, 2.5, 5 and 10 μM |
Incubation Time: | 24 h for AKT, 48 h for Bcl-Xl |
Result: |
Bound to enolase in cell lysate and bound to purified enolase.
Decreased the expression of AKT and Bcl-Xl, which are negative regulators of apoptosis. |
Cell Invasion Assay [1]
Cell Line: | HCT116 |
Concentration: | 0.156, 0.312, 0.625, 1.25 and 2.5 μM |
Incubation Time: | 24 h |
Result: | Significantly inhibits cancer cell invasion at a treatment concentration of 0.625 μM. |
Cell Migration Assay [1]
Cell Line: | HCT116 |
Concentration: | 0.625, 1.25 and 2.5 μM |
Incubation Time: | 24 h |
Result: | Inhibited cell migration dose-dependently. |
RT-PCR [1]
Cell Line: | Huh7 and HEK |
Concentration: | 10 μM |
Incubation Time: | 24 h |
Result: | Induced glucose uptake and inhibited PEPCK expression. |
AP-III-a4 (ENOblock) (10 μM; 96 h) inhibits cancer cell metastasis and suppresses the gluconeogenesis regulator PEPCK in zebrafish [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | The zebrafish cancer cell HCT116 xenograft model [1] |
Dosage: | 10 μM |
Administration: | 96 h |
Result: | Reduced cancer cell dissemination. Inhibited PEPCK expression and induced glucose uptake. Inhibited adipogenesis and foam cell formation. |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : ≥ 53 mg/mL ( 83.97 mM )
H 2 O : < 0.1 mg/mL (insoluble)
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.5843 mL | 7.9217 mL | 15.8433 mL |
5 mM | 0.3169 mL | 1.5843 mL | 3.1687 mL |
10 mM | 0.1584 mL | 0.7922 mL | 1.5843 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.